Cargando…

Synthesis and antiplasmodial assessment of nitazoxanide and analogs as new antimalarial candidates

During the last years, the progression to control malaria disease seems to be slowed and WHO (World Health Organization) reported a modeling analysis with the prediction of the increase in malaria morbidity and mortality in sub-Saharan Africa during the COVID-19 pandemic. A rapid way to the discover...

Descripción completa

Detalles Bibliográficos
Autores principales: Irabuena, Camila, Scarone, Laura, de Souza, Guilherme Eduardo, Aguiar, Anna Caroline Campos, Mendes, Giovana Rossi, Guido, Rafael Victorio Carvalho, Serra, Gloria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8794615/
https://www.ncbi.nlm.nih.gov/pubmed/35106047
http://dx.doi.org/10.1007/s00044-021-02843-1
Descripción
Sumario:During the last years, the progression to control malaria disease seems to be slowed and WHO (World Health Organization) reported a modeling analysis with the prediction of the increase in malaria morbidity and mortality in sub-Saharan Africa during the COVID-19 pandemic. A rapid way to the discovery of new drugs could be carried out by performing investigations to identify drugs based on repurposing of “old” drugs. The 5-nitrothiazole drug, Nitazoxanide was shown to be active against intestinal protozoa, human helminths, anaerobic bacteria, viruses, etc. In this work, Nitazoxanide and analogs were prepared using two methodologies and evaluated against P. falciparum 3D7. A bithiazole analog, showed attractive inhibitory activity with an EC(50) value of 5.9 μM, low propensity to show toxic effect against HepG2 cells at 25 μM, and no cross-resistance with standard antimalarials.